Coherus BioSciences, Inc. (CHRS) Operating Income (Loss) USD 2013 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Coherus BioSciences, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2013 to 2024.
  • Coherus BioSciences, Inc. Operating Income (Loss) for the quarter ending March 31, 2024 was -$42.5 M, a 37.2% increase year-over-year.
  • Coherus BioSciences, Inc. Operating Income (Loss) for the twelve months ending March 31, 2024 was -$178 M, a 27% increase year-over-year.
  • Coherus BioSciences, Inc. annual Operating Income (Loss) for 2023 was -$203 M, a 20.9% increase from 2022.
  • Coherus BioSciences, Inc. annual Operating Income (Loss) for 2022 was -$257 M, a 2.65% increase from 2021.
  • Coherus BioSciences, Inc. annual Operating Income (Loss) for 2021 was -$264 M, a 269% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$178 M -$42.5 M +$25.2 M +37.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$203 M -$68.9 M -$17.4 M -33.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-15
Q3 2023 -$186 M -$32 M +$48.4 M +60.2% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-06
Q2 2023 -$234 M -$34.5 M +$9.47 M +21.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-02
Q1 2023 -$244 M -$67.7 M +$13.2 M +16.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$257 M -$51.5 M -$11.9 M -30.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-15
Q3 2022 -$245 M -$80.4 M -$47.7 M -145% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-06
Q2 2022 -$197 M -$44 M -$19.8 M -82.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 -$177 M -$80.9 M +$86.4 M +51.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 -$264 M -$39.5 M -$56 M -341% Oct 1, 2021 Dec 31, 2021 10-K 2024-03-15
Q3 2021 -$208 M -$32.8 M -$66.5 M -197% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$141 M -$24.2 M -$89.5 M -137% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 -$51.9 M -$167 M -$208 M -510% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $156 M $16.4 M -$28.6 M -63.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-06
Q3 2020 $185 M $33.7 M -$18.1 M -35% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-08
Q2 2020 $203 M $65.3 M +$37.8 M +138% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $165 M $40.9 M +$57.5 M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $108 M $45 M +$106 M Oct 1, 2019 Dec 31, 2019 10-K 2022-02-23
Q3 2019 $2.23 M $51.8 M +$109 M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$107 M $27.5 M +$72.4 M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$179 M -$16.6 M +$25.4 M +60.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$204 M -$60.5 M -$14 M -30.2% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 -$190 M -$57 M -$357 K -0.63% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$190 M -$44.9 M +$11.7 M +20.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-05
Q1 2018 -$202 M -$42 M +$30.4 M +42% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$232 M -$46.5 M +$27 M +36.7% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 -$259 M -$56.6 M -$141 M -167% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$118 M -$56.6 M +$6.1 M +9.72% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 -$124 M -$72.4 M -$8.07 M -12.5% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$116 M -$73.5 M -$21.3 M -40.7% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 -$94.7 M $84.6 M +$156 M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 -$251 M -$62.7 M -$3.84 M -6.52% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 -$247 M -$64.4 M -$27.6 M -75.1% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q4 2015 -$219 M -$52.2 M -$25.6 M -96.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-08
Q3 2015 -$193 M -$71.2 M -$64.8 M -1009% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$129 M -$58.9 M -$41 M -228% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$87.7 M -$36.7 M -$23 M -167% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-09
Q4 2014 -$64.7 M -$26.6 M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-14
Q3 2014 -$6.42 M +$360 K +5.31% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-10
Q2 2014 -$17.9 M Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q1 2014 -$13.8 M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 -$6.78 M Jul 1, 2013 Sep 30, 2013 10-Q 2014-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.